share_log

Ayala Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-I.B.F Management Ltd.(28.0%),Israel Biotech Fund I, L.P.(20.9%), etc.

SEC ·  Oct 31, 2023 19:05
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.